Vol. 4 No. 01 (2026), Articles
Vol. 4 No. 01 (2026)

OQ QON KASALLIGI YOKI LEYKIMIYA

Articles
Published 2026-02-01
  • Qurbonova Gulnoza Abdirahimovna
  • Kibriyeva Maxfirat
  • Xolmirzayev Muhammadjon Ibrohim o’g’li
Qurbonova Gulnoza Abdirahimovna
Kibriyeva Maxfirat
Xolmirzayev Muhammadjon Ibrohim o’g’li
PDF
DOI

Keywords

Oq qon kasalligi, Leykemiya, Akut leykemiya, Xronik leykemiya,Qon tizimi,Suyak iligi, Oq qon hujayralari, Kimyoterapiya, Radioterapiya,, Suyak iligi transplantatsiyasi, Biologik terapiya, Limfoblastik leykemiya, Miyeloid leykemiya, Genetik faktorlar, Infektsiyalar,Tumor markerlar, Tibbiy diagnostika, Klinik tadqiqotlar, Qon testi, Suyak iligi biopsiyasi.

How to Cite

OQ QON KASALLIGI YOKI LEYKIMIYA. (2026). Yangi O’zbekistonda Tabiiy Va Ijtimoiy-Gumanitar Fanlar Respublika Ilmiy Amaliy Konferensiyasi, 4(01), 393-408. https://universalpublishings.com/index.php/gumanitar/article/view/16528
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Oq qon kasalligi (leykemiya) — bu asosan qonning oq qon hujayralarining patologik o'sishi va ko'payishi bilan bog'liq bo'lgan onkologik kasallikdir. Ushbu maqola oq qon kasalligining turli shakllari, klinik tasnifi, etiologiyasi, diagnostikasi va davolash usullari haqida umumiy ma'lumot beradi. Oq qon kasalligining kashfiyotlari, genetik va molekulyar mexanizmlar bo'yicha yangi ilmiy tadqiqotlar natijalari ko'rib chiqiladi. 

PDF
DOI

References

1. Oksford universiteti. (2021). Advances in Cancer Therapy. Oxford University Press.

2. Garvard universiteti. (2020). Recent Developments in Cancer Research and Treatment. Harvard Medical School Publications.

3. Jahon sog‘liqni saqlash tashkiloti (JSST). (2020). Global Cancer Statistics 2020. World Health Organization.

4. Edhacare.com. (2021). Cutting-edge treatments for brain tumor. https://www.edhacare.com.

5. Jurnal of Cancer Research and Therapy. (2021). Targeted Cancer Therapy: Current Approaches and Future Directions. 39(4), 555-563.